Company profile
Evommune, Inc. insider acquisitions
Company CIK 0002044725 · Reported insider acquisitions and filing context.
EVMN · NYSE
These are company listings. A transaction is linked to a particular security only when the filing provides enough information.
Company activity summary
By transaction date, as of October 23, 2026.
| Type / code | Reported security | Transactions | Known purchase value | Missing amounts |
|---|---|---|---|---|
| Stock awardCode A | Common StockNon-derivative · Currency not specified | 1 | Not applicable | 0 |
Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.
Transaction timeline
Who reported an acquisition, and when the transaction occurred.
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition
33 dated transactions · 8 of 16 reporting owners shown. Select one owner to focus the chart.
View timeline as a table
| Transaction date | Company / security | Reporting owners | Acquisition type |
|---|---|---|---|
| Sep 30, 2026 | Evommune, Inc.Common Stock | Pena Luis C. | Stock award |
| Dec 19, 2025 | Evommune, Inc.Common Stock | Hopfner Robert Lorne | Purchase |
| Dec 8, 2025 | Evommune, Inc.Employee Stock Option (Right to Buy) | Bauer Eugene | Stock award |
| Nov 7, 2025 | Evommune, Inc.Common Stock | Verduyn-van Weegen Felice Isabel | Purchase |
| Nov 7, 2025 | Evommune, Inc.Common Stock | Verduyn-van Weegen Felice Isabel | Conversion |
| Nov 7, 2025 | Evommune, Inc.Common Stock | Patel Jeegar Pravinkumar | Conversion |
| Nov 7, 2025 | Evommune, Inc.Common Stock | Drew Janice Suzann | Conversion |
| Nov 7, 2025 | Evommune, Inc.Common Stock | LSP 7 Cooperative UA | Purchase |
| Nov 7, 2025 | Evommune, Inc.Common Stock | LSP 7 Cooperative UA | Conversion |
| Nov 7, 2025 | Evommune, Inc.Common Stock | Carver Kyle | Conversion |
| Nov 7, 2025 | Evommune, Inc.Common Stock | Moss Gregory S. | Conversion |
| Nov 7, 2025 | Evommune, Inc.Common Stock | Bauer Eugene | Conversion |
| Nov 7, 2025 | Evommune, Inc.Common Stock | Pena Luis C. | Conversion |
| Nov 7, 2025 | Evommune, Inc.Common Stock | Hopfner Robert Lorne | Conversion |
| Nov 7, 2025 | Evommune, Inc.Common Stock | Hopfner Robert Lorne | Conversion |
| Nov 7, 2025 | Evommune, Inc.Common Stock | Hopfner Robert Lorne | Conversion |
| Nov 7, 2025 | Evommune, Inc.Common Stock | Hopfner Robert Lorne | Conversion |
| Nov 7, 2025 | Evommune, Inc.Common Stock | Cohen David E | Conversion |
| Nov 7, 2025 | Evommune, Inc.Common Stock | RA CAPITAL MANAGEMENT, L.P. | Purchase |
| Nov 7, 2025 | Evommune, Inc.Common Stock | RA CAPITAL MANAGEMENT, L.P. | Purchase |
| Nov 7, 2025 | Evommune, Inc.Common Stock | RA CAPITAL MANAGEMENT, L.P. | Conversion |
| Nov 7, 2025 | Evommune, Inc.Common Stock | RA CAPITAL MANAGEMENT, L.P. | Conversion |
| Nov 7, 2025 | Evommune, Inc.Common Stock | Pivotal bioVenture Partners Fund I, L.P. · Pivotal bioVenture Partners Fund I U.G.P. Ltd · Pivotal bioVenture Partners Fund I G.P., L.P. | Conversion |
| Nov 7, 2025 | Evommune, Inc.Common Stock | Pivotal bioVenture Partners Fund I, L.P. · Pivotal bioVenture Partners Fund I U.G.P. Ltd · Pivotal bioVenture Partners Fund I G.P., L.P. | Conversion |
| Nov 7, 2025 | Evommune, Inc.Common Stock | Pivotal bioVenture Partners Fund I, L.P. · Pivotal bioVenture Partners Fund I U.G.P. Ltd · Pivotal bioVenture Partners Fund I G.P., L.P. | Conversion |
| Nov 5, 2025 | Evommune, Inc.Employee Stock Option (Right to Buy) | Patel Jeegar Pravinkumar | Stock award |
| Nov 5, 2025 | Evommune, Inc.Employee Stock Option (Right to Buy) | Drew Janice Suzann | Stock award |
| Nov 5, 2025 | Evommune, Inc.Employee Stock Option (Right to Buy) | Carver Kyle | Stock award |
| Nov 5, 2025 | Evommune, Inc.Employee Stock Option (Right to Buy) | Moss Gregory S. | Stock award |
| Nov 5, 2025 | Evommune, Inc.Employee Stock Option (Right to Buy) | Pena Luis C. | Stock award |
| Nov 5, 2025 | Evommune, Inc.Stock Option (Right to Buy) | Cohen David E | Stock award |
| Nov 5, 2025 | Evommune, Inc.Stock Option (Right to Buy) | KIRSCH ARTHUR S | Stock award |
| Nov 5, 2025 | Evommune, Inc.Stock Option (Right to Buy) | MCGRAW BENJAMIN F III | Stock award |
Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.
Share price & reported acquisitions
Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.
Price history is not available
Market-price history is not connected yet.
EVMN · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.
Reported acquisitions
Filing-date filters apply to the list and timeline. The summary above uses transaction dates.
| Filed / transacted | Reporting owners | Type / security | Quantity | Price / reference value | Details |
|---|---|---|---|---|---|
| Trade: | Pena Luis C.President & CEO · Director | Stock awardCommon StockNon-derivative security · Code A | 1,115 | 7.02 *Value: 7,827.3Currency not specified | View ↗ |
| Trade: | Hopfner Robert LorneDirector · 10% owner | PurchaseCommon StockNon-derivative security · Code P | 1,000 | 17.35Value: 17,350Currency not specified | View ↗ |
| Trade: | Bauer EugeneChief Medical Officer · Director | Stock awardEmployee Stock Option (Right to Buy)Derivative security · Code A | 100,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Verduyn-van Weegen Felice IsabelDirector · 10% owner | PurchaseCommon StockNon-derivative security · Code P | 1,562,500 | 16Value: 25,000,000Currency not specified | View ↗ |
| Trade: | Verduyn-van Weegen Felice IsabelDirector · 10% owner | ConversionCommon StockNon-derivative security · Code C | 3,367,133 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Patel Jeegar PravinkumarChief Scientific Officer | ConversionCommon StockNon-derivative security · Code C | 3,175 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Drew Janice SuzannEVP, Operations | ConversionCommon StockNon-derivative security · Code C | 1,587 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | LSP 7 Cooperative UA10% owner | PurchaseCommon StockNon-derivative security · Code P | 1,562,500 | 16Value: 25,000,000Currency not specified | View ↗ |
| Trade: | LSP 7 Cooperative UA10% owner | ConversionCommon StockNon-derivative security · Code C | 3,367,133 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Carver KyleChief Financial Officer | ConversionCommon StockNon-derivative security · Code C | 3,175 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Moss Gregory S.Chief Business & Legal Officer | ConversionCommon StockNon-derivative security · Code C | 3,175 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Bauer EugeneChief Medical Officer · Director | ConversionCommon StockNon-derivative security · Code C | 25,812 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Pena Luis C.President & CEO · Director | ConversionCommon StockNon-derivative security · Code C | 24,225 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Hopfner Robert LorneDirector · 10% owner | ConversionCommon StockNon-derivative security · Code C | 294,502 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Hopfner Robert LorneDirector · 10% owner | ConversionCommon StockNon-derivative security · Code C | 1,632,441 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Hopfner Robert LorneDirector · 10% owner | ConversionCommon StockNon-derivative security · Code C | 1,441,032 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Hopfner Robert LorneDirector · 10% owner | ConversionCommon StockNon-derivative security · Code C | 3,026 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Cohen David EDirector | ConversionCommon StockNon-derivative security · Code C | 6,056 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | RA CAPITAL MANAGEMENT, L.P.Director · 10% owner | PurchaseCommon StockNon-derivative security · Code P | 92,904 | 16Value: 1,486,464Currency not specified | View ↗ |
| Trade: | RA CAPITAL MANAGEMENT, L.P.Director · 10% owner | PurchaseCommon StockNon-derivative security · Code P | 1,157,096 | 16Value: 18,513,536Currency not specified | View ↗ |
| Trade: | RA CAPITAL MANAGEMENT, L.P.Director · 10% owner | ConversionCommon StockNon-derivative security · Code C | 691,441 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | RA CAPITAL MANAGEMENT, L.P.Director · 10% owner | ConversionCommon StockNon-derivative security · Code C | 1,517,329 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Pivotal bioVenture Partners Fund I, L.P.Director · 10% owner Pivotal bioVenture Partners Fund I U.G.P. LtdDirector · 10% owner Pivotal bioVenture Partners Fund I G.P., L.P.Director · 10% owner Joint filing · amounts unallocated | ConversionCommon StockNon-derivative security · Code C | 294,502 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Pivotal bioVenture Partners Fund I, L.P.Director · 10% owner Pivotal bioVenture Partners Fund I U.G.P. LtdDirector · 10% owner Pivotal bioVenture Partners Fund I G.P., L.P.Director · 10% owner Joint filing · amounts unallocated | ConversionCommon StockNon-derivative security · Code C | 1,632,441 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Pivotal bioVenture Partners Fund I, L.P.Director · 10% owner Pivotal bioVenture Partners Fund I U.G.P. LtdDirector · 10% owner Pivotal bioVenture Partners Fund I G.P., L.P.Director · 10% owner Joint filing · amounts unallocated | ConversionCommon StockNon-derivative security · Code C | 1,441,032 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Patel Jeegar PravinkumarChief Scientific Officer | Stock awardEmployee Stock Option (Right to Buy)Derivative security · Code A | 179,619 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Drew Janice SuzannEVP, Operations | Stock awardEmployee Stock Option (Right to Buy)Derivative security · Code A | 231,274 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Carver KyleChief Financial Officer | Stock awardEmployee Stock Option (Right to Buy)Derivative security · Code A | 279,408 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Moss Gregory S.Chief Business & Legal Officer | Stock awardEmployee Stock Option (Right to Buy)Derivative security · Code A | 293,496 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Pena Luis C.President & CEO · Director | Stock awardEmployee Stock Option (Right to Buy)Derivative security · Code A | 796,841 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Cohen David EDirector | Stock awardStock Option (Right to Buy)Derivative security · Code A | 37,960 | 0Value: 0Currency not specified | View ↗ |
| Trade: | KIRSCH ARTHUR SDirector | Stock awardStock Option (Right to Buy)Derivative security · Code A | 37,960 | 0Value: 0Currency not specified | View ↗ |
| Trade: | MCGRAW BENJAMIN F IIIDirector | Stock awardStock Option (Right to Buy)Derivative security · Code A | 37,960 | 0Value: 0Currency not specified | View ↗ |
33 transactions on this page. Filing date, newest first.
Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →